To the Editor: Rothenberg and colleagues (March 20 issue)¹ provide data on the use of mepolizumab, an anti–interleukin-5 monoclonal antibody, for corticosteroid sparing in patients with non–life-threatening hypereosinophilic syndrome who were negative ...

To the Editor: Koch et al. (March 20 issue)¹ report increased risks of postoperative complications and death among patients undergoing cardiac surgery who were given blood that had been stored for more than 2 weeks, as compared with those given newer ...

To the Editor: The article by Jha et al. (March 13 issue)¹ on the large and growing number of deaths in India due to smoking draws attention to the need for effective implementation of the national tobacco control act of 2003 in India.² Recent data show ...

To the Editor: In their review article, Munoz-Price and Weinstein (March 20 issue)¹ state that “Acinetobacter is a gram-negative coccobacillus” and that it is “nonreactive in many biochemical tests commonly used to differentiate among gram-negative ...

To the Editor: In the Perspective article by Cohen et al. (Feb. 14 issue),¹ a narrow construction of what constitutes prevention leads to erroneous conclusions about its potential impact and cost-effectiveness. The authors do not address preventive ...

To the Editor: As reported by Shulman et al. (Jan. 31 issue),¹ the first signs of a malignant condition in a young pregnant woman with lymphoma involving the mediastinum and left breast were noted at 26.1 weeks' gestation, and a live-born infant was ...

To the Editor: Primary coenzyme Q10 deficiency is considered to be the only treatable mitochondrial disorder, since patients have a response to oral coenzyme Q10 supplementation. The disease usually manifests with nephropathy and encephalomyopathy.¹ It ...